Public Company News

CITI RECOGNISED AS BEST INTERNATIONAL BANK IN SINGAPORE IN RECORD HAUL AT THE EUROMONEY AWARDS FOR EXCELLENCE 2025

* Citi also named Best Investment Bank for M&A in Singapore * CEO Jane Fraser named Banker of the Year * Over 50 awards recognize Citi's global network SINGAPORE, July 24, 2025 /PRNewswire/ -- Citi has been named the Best International Bank and Best Investment Bank for M&A inSingapore at the...

2025-07-24 16:31 2965

Kerry Expands Innovation Footprint in Southeast Asia with New Jakarta Office and RD&A Facility

JAKARTA, Indonesia, July 24, 2025 /PRNewswire/ -- Kerry , a global leader in taste and nutrition, officially opened an expanded office and Research, Development & Applications (RD&A) facility in RDTX Place, Kuningan,South Jakarta, reinforcing its commitment to foster co-cr...

2025-07-24 16:13 4131

Yealink and TÜV SÜD Announce Strategic Partnership to Advance Compliance, Security, and Sustainability

XIAMEN, China, July 24, 2025 /PRNewswire/ -- Yealink, the world-leading provider of unified communication and collaboration solutions has signed a strategic cooperation agreement with TÜV SÜD, a global leader in testing, inspection, and certification. This partnership marks a significant step in ...

2025-07-24 15:00 2286

Elitery a Pioneering MSSP Partner for Google Cloud's "Indonesia BerdAIa untuk Keamanan Siber" Program: A Strategic Move to Strengthen National Cyber Resilience

JAKARTA, Indonesia, July 24, 2025 /PRNewswire/ -- PT Data Sinergitama Jaya Tbk (Elitery) today announced that it will be a pioneering local Managed Security Service Provider (MSSP) partner for Google Cloud's "Indonesia BerdAIa untuk Keamanan Siber" program, which is designed to empower organizati...

2025-07-24 10:15 3712

Akeso Announces First Patient Enrollment in Phase III Trial of Ivonescimab for Pancreatic Cancer

HONG KONG, July 23, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase III clinical trial (AK112-310/HARMONi-GI2) of ivonescimab, a first-in-class PD-1/VEGF bispecific antibody dev...

2025-07-24 09:14 1763

Desay Battery Unveils Proactive-Safety-Focused Energy Storage Technologies

CHANGSHA, China, July 24, 2025 /PRNewswire/ -- On July 23, Desay Battery, a leading global provider of comprehensive energy storage solutions, held its mass production launch event inChangsha, China. The event showcased a new generation of proactive safety battery cells and systems, UPS 2.0, and ...

2025-07-24 09:00 3444

Instructure Launches IgniteAI to Simplify and Seamlessly Transform AI Integration in Education

Powered by AWS, IgniteAI sets the stage for a future-ready, open ecosystem with agentic support as the AI landscape continues to expand SALT LAKE CITY, July 24, 2025 /PRNewswire/ -- Instructure, the world's leading edtech ecosystem and maker ofCanvas Learning Management System (LMS), today annou...

2025-07-24 07:02 1614

SK hynix Announces 2Q25 Financial Results

* Reports revenues of 22.232 trillion won, operating profit of 9.2129 trillion won, net profit of 6.9962 trillion won * Both revenues, operating profit at all-time highs following brisk sales of AI memory * Company to provide best-in-class AI products timely for customer satisfaction, marke...

2025-07-24 06:47 2650

Cboe Plans to Cease Japanese Equities Operations

* Cboe will maintain presence in Japan for its Global Derivatives and Cboe Data Vantage businesses CHICAGO and TOKYO, July 24, 2025 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), the world's leading derivatives and securities exchange network, today announced its decision to wind down ...

2025-07-24 06:00 2014

Kelun-Biotech's Partner Windward Bio Announces Initiation of a Global Phase 2 Asthma Trial of SKB378/WIN378

CHENGDU, China, July 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or "the Company", HKEX: 6990) today announced that its partner, Windward Bio AG ("Windward Bio") has launched its Phase 2 POLARIS clinical study, assessing long-acting dosing of SKB37...

2025-07-23 21:31 3279

NYSE Content Advisory: Pre-market update + NIQ to debut, NYSE joins AI Summit

NEW YORK, July 23, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. The NYSE is participating at the All In and Hill and Valley's "Winning the AI Race" Summit, capturing insights from key voices shaping the future of ...

2025-07-23 21:29 2389

Health In Tech to Host Independent InsurTech Summit in Davos During World Economic Forum Week 2026

STUART, Fla., July 23, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce it will host an exclusive half-day Summit onJanuary 20, 2026, from  11:30 a.m. to 4:30 p.m. (CET) at the prestigious Belvedere Hotel in...

2025-07-23 21:15 2278

NovaSource Power Services Named O&M Partner for Landmark Melbourne Renewable Energy Hub in Australia

CHANDLER, Ariz., July 23, 2025 /PRNewswire/ -- NovaSource Power Services ("NovaSource"), the world's largest solar operations and maintenance ("O&M") provider, has been selected by Equis as the long-term O&M partner for the Melbourne Renewable Energy Hub ("MREH"), a groundbreaking project set to ...

2025-07-23 21:00 2177

HBM9378/WIN378, a Long-Acting, Fully Human Anti-TSLP Antibody, Enters Global Phase 2 POLARIS Trial for Asthma

* Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of HBM9378/WIN378 in patients with asthma, with an initial data readout expected in mid-2026 * HBM9378/WIN378 has the potential to be the first-to-market long-acting anti-TSLP antibody with twice-yearly dosing for asthma ...

2025-07-23 20:36 2465

Infosys: Industry-leading Sequential Growth of 2.6% in CC, Driven by Differentiated Value Proposition in Enterprise AI

- Large Deal Wins at $3.8 Billion with 55% Net New; Demonstrating Deep Competitive Advantage in Consolidation Play - FY26 Revenue Guidance Revised to 1%-3% and Margin Guidance Retained at 20%-22% BENGALURU, India, July 23, 2025 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a glob...

2025-07-23 20:19 3463

Health In Tech Donates 60 Computers to Diocese of Srikakulam to Empower Education and Community Development

STUART, Fla., July 23, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is pleased to announce its donation of 60 new computers to the Diocese of Srikakulam, furthering educational opportunities and digital inclusion for childre...

2025-07-23 18:30 2294

IFS Surges Ahead in H1 2025: 30% ARR Growth and Breakthrough Agentic AI Cement Industrial Leadership

Compelling industrial AI use cases, strong execution and AI-driven demand fuel global growth LONDON, July 23, 2025 /PRNewswire/ -- IFS, the leading provider of enterprise cloud and Industrial AI software, today announced record-setting H1 2025 results. The company is rewriting the rules of enter...

2025-07-23 16:35 2114

NetDragon Achieves "A" Rating in Wind ESG Assessment, Demonstrating Strong Commitment to Sustainable Development Principles

HONG KONG, July 23, 2025 /PRNewswire/ -- NetDragon Websoft Holdings Limited ("NetDragon" or the "Company", Hong Kong Stock Code: 777), a global leader in building internet communities, is pleased to announce that it has achieved an "A" rating in the latest 2025 ESG assessment conducted by Wind In...

2025-07-23 15:08 3311

Zylox-Tonbridge Issues Positive Profit Alert, Expects Over RMB 115 Million in 1H 2025 Net Profit

HANGZHOU, China, July 23, 2025 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, "Zylox-Tonbridge" or the "Company"), a leading medical device company inChina's peripheral and neurovascular interventional market, today announced a positive profit alert for the six months ...

2025-07-23 14:57 3487

Samsung Biologics reports second quarter 2025 financial results

* Recorded Q2'25 consolidated revenue of KRW 1,289.9 billion * Recorded Q2'25 consolidated operating profit of KRW 475.6 billion * Solid momentum sustained through capacity ramp-up and stable project execution INCHEON, South Korea, July 23, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940...

2025-07-23 14:54 2755